Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+Mozilla Firefox 20+Internet Explorer 11Opera 15–18Apple Safari 7SeaMonkey 2.15-2.23

ESMO Preceptorship on Metastatic Bladder and Kidney Cancer 2021

ESMO-Preceptorship-Metastatic-Bladder-Kidney-Cancer-2021-1000x250-December-Lugano
Start date
03 Dec 2021
End date
04 Dec 2021
Location
Lugano, Switzerland
Application deadline
Closed

Learning objectives

  • To learn about fundamentals of molecular pathology and diagnosis as contributing factors to heterogeneity in bladder and kidney cancer
  • To understand essentials in the assessment and multidisciplinary treatment of bladder and kidney cancer
  • To learn about advances in treatment and novel targets in bladder and kidney cancer

Download the preliminary programme

How to apply

Application is via online form. During the application process you will be required to upload the following:

Application deadline

Applications for the course are now closed.

Who can apply?

While this course is primarily aimed at oncologists resident in Europe, application is open to all ESMO members.

To apply, ESMO membership is mandatory. If you are not an ESMO member, or need to renew your membership, please visit the ESMO membership pages

Participation

All participants must follow the COVID 19 regulations* below.

ESMO will apply COVID-19 regulations according to the latest local authority guidelines and requirements.

To enter the hotel/meeting venue, faculty, delegates, sponsors and staff will be required to show:

  • A certificate providing evidence of being fully vaccinated against COVID-19 (WHO and EMA approved vaccines),

OR

  • A certificate showing proof of recovery from COVID-19 in the last 6 months

Additionally, for all it is requested:

  • Proof of negative PCR test or rapid antigen test not older than 48 hours.

The above-mentioned certificates will be checked at the entrance door.

In addition, the following health and hygiene measures will be applied:

  • Hydro-alcoholic gel will be made available outside the rooms/at specific points
  • Wearing face masks is compulsory inside the hotel/meeting room 

Note: All people entering CH, are required to complete an online entry form -  Please click here.

*Any changes to the COVID 19 regulations will be communicated on this webpage.

What's included?

Successful applicants will benefit from complimentary course registration and accommodation.

Travel Grant

In addition to the course registration and the hotel accommodation, a travel grant of maximum 600 euros is offered to selected applicants as a contribution versus their travel costs. The reimbursement will be processed after the course against original invoices/vouchers. Please be aware that visa costs are NOT covered by the travel grant and are the participant's responsibility.

Accreditation

The programme of this event has been accredited with 10 ESMO-MORA category 1 points. Recertification is necessary for medical oncologists to remain professionally certified by ESMO. Recertification guarantees that a certified medical oncologist has continued to update her/his knowledge and continues to possess the necessary skills and standards for the practice of medical oncology. For further details, please refer to ESMO-MORA Recertification Process & Requirements.

Co-Chairs

  • Laurence Albiges, France
  • Viktor Grünwald, Germany

Venue and accommodation

Course venue:

Hotel de la Paix
Viale Giuseppe Cattori 18
6900 Lugano, Switzerland

Faculty and delegates accommodation:

Novotel Lugano Paradiso
Viale San Salvatore 11
6900 Lugano-Paradiso, Switzerland

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings